Branch Therapeutics
Developing orally bioavailable, multi-targeted cancer therapies to address key oncogenic drivers with improved safety and efficacy.
HQ location
Tucson, United States
Launch date
Enterprise value
$16—24m
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor | €0.0 | round | |
* | $4.0m | Seed | |
| Total Funding | 000k | ||
Related Content
Notes (0)
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads